Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas

Leukemia. 2007 Jul;21(7):1566-70. doi: 10.1038/sj.leu.2404699. Epub 2007 Apr 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytoplasm
  • Humans
  • Leukemia, Myeloid / genetics
  • Leukemia, Myeloid / pathology*
  • Mutation*
  • Nuclear Proteins / genetics*
  • Nucleophosmin
  • Sarcoma / genetics
  • Sarcoma / pathology*

Substances

  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin